1,960
Views
41
CrossRef citations to date
0
Altmetric
Original Articles

PLGA nanoparticles for ocular delivery of loteprednol etabonate: a corneal penetration study

, &
Pages 1156-1164 | Received 25 Apr 2016, Accepted 16 Jun 2016, Published online: 08 Jul 2016

References

  • Ahuja M, Dhake AS, Majumdar DK. 2006. Effect of formulation factors on in-vitro permeation of diclofenac from experimental and marketed aqueous eye drops through excised goat cornea. Yakugaku Zasshi. 126:1369–1375.
  • Aukunuru JV, Kompella UB. 2002. In vitro delivery of nano and microparticles to retinal pigment epithelial (RPE) cells. Drug Del Technol. 2:50–57.
  • Calvo P, Thomas C, Alonso MJ, Vila Jato JL, Robinson J. 1994. Study of the mechanisms of interaction of poly E-caprolactone nanocapsules with the cornea by confocal laser scanning microscopy. Int J Pharm. 103:283–291.
  • Das S, Suresh PK, Deshmukh R. 2010. Design of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug delivery. Nanomedicine. 6:318–323.
  • Gupta H, Aquil M, Khar RK, Ali A, Bhatnagar A, Mittal G. 2010. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine. 6:324–333.
  • Jain GK, Pathan SA, Akhter S, Jayabalan N, Talegaonkar S, Khar RK, Ahmad FJ. 2011. Microscopic and spectroscopic evaluation of novel PLGA-chitosan nanoplexes as an ocular delivery system. Colloids Surf B Biointerfaces. 82:397–403.
  • Katara R, Majumdar DK. 2013. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery. Colloids Surf B Biointerfaces. 103:455–462.
  • Kaur H, Ahuja M, Kumar S, Dilbaghi N. 2012. Carboxymethyl tamarind kernel polysaccharide nanoparticles for ophthalmic drug delivery. Int J Biol Macromol. 50:833–839.
  • Kohane DS, Tse JY, Yeo Y, Padera R, Shubina M, Robert L. 2006. Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum. J Biomed Mater Res A. 77:351–361.
  • Mainardes RM, Evangelista RC. 2005. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm. 290:137–144.
  • Mohanty B, Mishra SK, Majumdar DK. 2013. Effect of formulation factors on in vitro transcorneal permeation of voriconazole from aqueous drops. J Adv Pharm Technol Res. 4:210–216.
  • Muller RH, Jacob C. 2002. Production and characterization of a budenoside nanosuspension for pulmonary administration. Pharm Res. 19:189–194.
  • Pescina S, Govoni P, Potenza A, Padula C, Santi P, Nicoli S. 2015. Development of a convenient ex vivo model for the study of the transcorneal permeation of drugs: histological and permeability evaluation. J Pharm Sci. 104:63–71.
  • Pignatello R, Bucolo C, Ferrar P, Maltese A, Puleo A, Puglisi G. 2002. Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci. 16:53–61.
  • Qaddoumi MG, et al. 2004. The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers. Pharm Res. 21:641–648.
  • Qaddoumi MG, Gukasyan HJ, Davda J, Labhasetwar V, Kim KJ, Lee HLV. 2003. Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis. Mol Vision. 9:559–568.
  • Rafie F, Javadzadeh Y, Javadzadeh AR, Ghavidel LA, Jafari B, Moogooee M, Davaran S. 2010. In vivo evaluation of novel nanoparticles containing dexamethasone for ocular drug delivery on rabbit eye. Curr Eye Res. 35:1081–1089.
  • Rathore MS, Majumdar DK. 2006. Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops. AAPS PharmSciTech. 7:57.
  • Sah AK, Jain SK, Pandey RS. 2011. Microemulsion based hydrogel formulation of methoxsalen for the effective treatment of psoriasis. Asian J Pharm Clin Res. 4:140–145.
  • Sahu AK, Kumar T, Jain V. 2014. Formulation optimization of erythromycin solid lipid nanocarrier using response surface methodology. BioMed Res Int. 2014. doi:http://dx.doi.org/10.1155/2014/689391.
  • Sarwa KK, Suresh PK, Rudrapal M, Verma VK. 2014. Penetration of tamoxifen citrate loaded ethosomes and liposomes across human skin: a comparative study with confocal laser scanning microscopy. Curr Drug Deliv. 11:332–337.
  • Sabzevari A, Adibkia K, Hashemi H, Hedayatfar A, Mohsenzadeh N, Atyabi F, Ghahremani MH, Dinarvand R. 2013. Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies. Eur J Pharm Biopharm. 84:63–71.
  • Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. 2001. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 70:1–20.
  • Souza JG, Dias K, Pereira TA, Bernardi DS, Lopez RFV. 2013. Topical delivery of ocular therapeutics: carrier systems and physical methods. J Pharm Pharmacol. 66:507–530.
  • Yadav M, Ahuja M. 2010. Preparation and evaluation of nanoparticles of gum cordia, an anionic polysaccharide for ophthalmic delivery. Carbohydr Polym. 81:871–877.
  • Yasueda SI, Higashiyama M, Shirasaki Y, Inada K, Ohtori A. 2004. An HPLC method to evaluate purity of a steroidal drug, loteprednol etabonate. J Pharm Biomed Anal. 36:309–316.
  • Zhang L, Li Y, Zhang C, Wang Y, Song C. 2009. Pharmacokinetics and tolerance study of intravitreal injection of dexamethasone-loaded nanoparticles in rabbits. Int J Nanomed. 4:175–183.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.